Regular readers of the Mental Elf will recall the blogs (Here is the evidence for exercising if you are depressed and New Cochrane review shows that exercise helps with depression) I wrote back in June and July about the evidence for exercising if you have depression. A new systematic review was published in the British [read the full story…]
Supporting carers with anticipatory grief for a loved one with dementia: systematic review
Caring for someone close to you with dementia can be a long and rocky road. Family carers often focus on the needs of their loved one and forget about their own health and wellbeing, which can make it harder to cope as time goes on. The relationship between the carer and the recipient of care [read the full story…]
First national bereavement survey published by the Department of Health
The Department of Health have published the results of the first nationwide survey of bereaved relatives in England. The survey looked at the last 3 months of life and assessed the quality of care that people received and how this varied in different parts of the country and in different groups of patients. The postal [read the full story…]
End of life care for people with dementia: new research briefing from SCIE
End of life care is an emotive subject and perhaps none more so than in people with dementia where it can be particularly difficult to ensure that individuals get the care they want in the final months of their life. Both the Department of Health and NICE have published guidance in this area and this [read the full story…]
Omega-3 fish oil supplements don’t help with cognitive decline or dementia in the short-term, according to new Cochrane review
Fish oil supplements are big business. The worldwide omega-3 market has recently been valued at around $5 billion with 40% growth predicted between 2010 and 2015. Omega-3 fatty acids are fats responsible for many important jobs in the body. We get these fats through our daily diets and the three major omega-3 fats are: Alpha [read the full story…]
Why is it so difficult to measure the prevalence of depression in people aged 75 and over?
A number of reviews have been published in recent years, which explore the prevalence of depression in old people. Prevalence rates vary enormously from one study to the next and so the reviews tend to report quite a wide range, typically up to 10%. Prevalence is defined as: “a measure of the proportion of people [read the full story…]
Memory clinics no better than GP care for post-diagnosis treatment of dementia, according to new RCT
Memory clinics are becoming more widespread in the UK and elsewhere. They offer assessment, support, information and advice to people with memory problems and their carers. GPs will often refer patients to memory clinics if they feel that they may be in the early stages of dementia, but need an assessment before a diagnosis can [read the full story…]
New CQUIN guidance focuses on identifying and referring people with dementia
The Commissioning for Quality and Innovation (CQUIN) payment framework enables commissioners to reward excellence by linking a proportion of providers’ income to the achievement of local quality improvement goals. The framework aims to embed quality within commissioner-provider discussions and to create a culture of continuous quality improvement, with stretching goals agreed in contracts on an [read the full story…]
Assessing the risk of suicide and self-harm in older people: results from new prospective cohort study
There is a clear need for specialist assessment and care for older people who self-harm, according to two papers published in the May issue of the British Journal of Psychiatry. Researchers from the University of Manchester studied 1,177 people over the age of 60 who were admitted to six general hospitals in Oxford, Manchester and Derby [read the full story…]
Cholinesterase inhibitors are an effective treatment for patients with Parkinson’s disease with dementia
People with Alzheimer’s disease experience a loss of nerve cells that use a chemical called acetylcholine as a chemical messenger. Dementia symptoms become more severe as more nerve cells are lost. Cholinesterase inhibitors are a group of drugs (including donepezil, rivastigmine and galantamine) that prevent the enzyme acetylcholinesterase from breaking down acetylcholine in the brain. [read the full story…]